Literature DB >> 10022120

Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation.

C Elly1, S Witte, Z Zhang, O Rosnet, S Lipkowitz, A Altman, Y C Liu.   

Abstract

Cbl-b, a mammalian homolog of Cbl, consists of an N-terminal region (Cbl-b-N) highly homologous to oncogenic v-Cbl, a Ring finger, and a C-terminal region containing multiple proline-rich stretches and potential tyrosine phosphorylation sites. In the present study, we demonstrate that upon engagement of the T cell receptor (TCR), endogenous Cbl-b becomes rapidly tyrosine-phosphorylated. In heterogeneous COS-1 cells, Cbl-b was phosphorylated on tyrosine residues by both Syk- (Syk/Zap-70) and Src- (Fyn/Lck) family kinases, with Syk kinase inducing the most prominent effect. Syk associates and phosphorylates Cbl-b in Jurkat T cells. A Tyr-316 Cbl-binding site in Syk was required for the association with and for the maximal tyrosine phosphorylation of Cbl-b. Mutation at a loss-of-function site (Gly-298) in Cbl-b-N disrupts its interaction with Syk. Cbl-b constitutively binds Grb2 and becomes associated with Crk-L upon TCR stimulation. The Grb2- and the Crk-L-binding regions were mapped to the C-terminus of Cbl-b. The Crk-L-binding sites were further determined to be Y655DVP and Y709KIP, with the latter being the primary binding site. Taken together, these results implicate that Cbl-b is involved in TCR-mediated intracellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022120     DOI: 10.1038/sj.onc.1202411

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Negative regulation of Rap1 activation by the Cbl E3 ubiquitin ligase.

Authors:  Yuan Shao; Chris Elly; Yun-Cai Liu
Journal:  EMBO Rep       Date:  2003-04       Impact factor: 8.807

Review 2.  Cbl-b in T-cell activation.

Authors:  Magdalena Paolino; Josef M Penninger
Journal:  Semin Immunopathol       Date:  2010-02-21       Impact factor: 9.623

Review 3.  Strategies to enhance NK cell function for the treatment of tumors and infections.

Authors:  Jacquelyn Freund-Brown; Leilani Chirino; Taku Kambayashi
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 4.  Roles of E3 ubiquitin ligases in cell adhesion and migration.

Authors:  Cai Huang
Journal:  Cell Adh Migr       Date:  2010-01-18       Impact factor: 3.405

5.  The rat diabetes susceptibility locus Iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection.

Authors:  Elizabeth P Blankenhorn; Lucy Rodemich; Cristina Martin-Fernandez; Jean Leif; Dale L Greiner; John P Mordes
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

Review 6.  c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.

Authors:  Christine B F Thien; Wallace Y Langdon
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

7.  Tyrosine phosphorylated c-Cbl regulates platelet functional responses mediated by outside-in signaling.

Authors:  Lorena Buitrago; Wallace Y Langdon; Archana Sanjay; Satya P Kunapuli
Journal:  Blood       Date:  2011-10-03       Impact factor: 22.113

8.  Anergic CD4+ T cells form mature immunological synapses with enhanced accumulation of c-Cbl and Cbl-b.

Authors:  Melissa Doherty; Douglas G Osborne; Diana L Browning; David C Parker; Scott A Wetzel
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

Review 9.  Regulation of immune responses by E3 ubiquitin ligase Cbl-b.

Authors:  Rong Tang; Wallace Y Langdon; Jian Zhang
Journal:  Cell Immunol       Date:  2018-11-07       Impact factor: 4.868

10.  c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment.

Authors:  Jae J Song; Joo-Hang Kim; Bo K Sun; Marco A Alcala; David L Bartlett; Yong J Lee
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.